UBS Group
BNTX icon

UBS Group’s BioNTech BNTX Stock Holding History

UBS Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5K Sell
500
-6,300
-93% -$593K ﹤0.01% 7610
2026
Q1 		$604K Sell
6,800
-43,800
-87% -$4.5M ﹤0.01% 5948
2025
Q4 		$4.82M Hold
50,600
– – ﹤0.01% 4066
2025
Q3 		$4.99M Hold
50,600
– – ﹤0.01% 4034
2025
Q2 		$5.39M Sell
50,600
-12,600
-20% -$1.27M ﹤0.01% 3796
2025
Q1 		$5.75M Sell
63,200
-43,700
-41% -$4.89M ﹤0.01% 3646
2024
Q4 		$12.2M Buy
106,900
+15,400
+17% +$1.76M ﹤0.01% 2843
2024
Q3 		$10.9M Buy
91,500
+37,400
+69% +$3.44M ﹤0.01% 2285
2024
Q2 		$4.35M Sell
54,100
-474,200
-90% -$43.3M ﹤0.01% 3005
2024
Q1 		$48.7M Buy
528,300
+390,300
+283% +$37.4M 0.01% 1053
2023
Q4 		$14.6M Buy
138,000
+17,000
+14% +$1.71M ﹤0.01% 1819
2023
Q3 		$13.1M Buy
+121,000
New +$13.4M ﹤0.01% 1773
2023
Q2 		– Sell
-25,000
Closed -$3.11M – 8950
2023
Q1 		$3.11M Sell
25,000
-16,100
-39% -$2.21M ﹤0.01% 2962
2022
Q4 		$6.17M Buy
+41,100
New +$6.32M ﹤0.01% 2299
2022
Q2 		– Sell
-4,100
Closed -$699K – 10332
2022
Q1 		$699K Sell
4,100
-95,900
-96% -$16.1M ﹤0.01% 4439
2021
Q4 		$25.8M Sell
100,000
-300
-0.3% -$82.2K 0.01% 1411
2021
Q3 		$27.4M Buy
100,300
+300
+0.3% +$95.3K 0.01% 1256
2021
Q2 		$22.4M Hold
100,000
– – 0.01% 1412
2021
Q1 		$10.9M Buy
+100,000
New +$10.6M ﹤0.01% 1878

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

UBS Group's BNTX Position: Q2 2026 in Review

UBS Group increased its BioNTech (BNTX) stake by 9.1% in Q2 2026, buying an estimated $2.05M and bringing the position to 262,361 shares worth $24.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2473.

UBS Group first reported a position in BNTX in Q4 2019 and has held it in 27 quarters since. The position peaked at $95.4M in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • UBS Group held 262,361 shares of BioNTech worth $24.4M as of Q2 2026.
  • UBS Group bought 21,823 BioNTech shares in Q2 2026, an estimated $2.05M.
  • BioNTech made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2473 holding.
  • UBS Group first reported a position in BioNTech in Q4 2019 and has held it in 27 quarters since.
  • UBS Group's BioNTech position peaked at $95.4M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.